Data compiled by Redley Lamar · ChainSifter Intelligence
7Suppliers
8Customers
1Debt Items
20Related Chains
Source-Backed Evidence Depth
Autolus Therapeutics plc (AUTL) is shown with relationship data already present in ChainSifter's database. Counts below come from stored supply-chain records and filing/source URLs where available; missing source URLs are not filled in or estimated.
17Total relationships
2Distinct source URLs
7High confidence
0.763Average confidence
2026-09-13Latest database update
ChainSifter does not infer unreported suppliers, customers, ownership, acquisitions, debt exposure, revenue dependency, or future supply-chain events on this public page.
Autolus Therapeutics plc Suppliers
Ticker
Name
Confidence
Evidence
AGC-BIOLOGICS-S-P-A
AGC-BIOLOGICS-S-P-A
92%
The Agreement replaces and supersedes the prior arrangement between the Company and AGC, pursuant to which AGC has provided similar products and services.
CONTRACT-RESEARCH-ORGANIZATION
CONTRACT-RESEARCH-ORGANIZATION
85%
Qualifying expenditures largely comprise of employment costs for research staff, consumables, outsourced contract research organization costs and utilities costs incurred as part of research projects…
Reciprocal relationship from BNTX graph: Reciprocal relationship from AUTL graph: Reciprocal relationship from BNTX graph: Reciprocal relationship from AUTL graph: Reciprocal relationship from BNTX g…
As the Product Options within the BioNTech License and Option Agreement were an embedded feature within a freestanding financial instrument, the Company assessed if the Product Options should be acco…
Reciprocal relationship from ARTV graph: Reciprocal relationship from AUTL graph: Reciprocal relationship from ARTV graph: Reciprocal relationship from AUTL graph: Reciprocal relationship from ARTV g…
Reciprocal relationship from CLLS graph: Reciprocal relationship from AUTL graph: Reciprocal relationship from CLLS graph: Reciprocal relationship from AUTL graph: Reciprocal relationship from CLLS g…
Reciprocal relationship from LEGN graph: supply chain disruptions, failure of financial institutions, rising inflation, tariffs and other world events; • comply with applicable legal and regulatory r…
Autolus Therapeutics plc Customers
Ticker
Name
Confidence
Evidence
NATIONAL-HEALTH-SERVICE
NATIONAL-HEALTH-SERVICE
90%
AUCATZYL is available through the National Health Service ("NHS") and private treatment centers.
Reciprocal relationship from BNTX graph: Reciprocal relationship from AUTL graph: Reciprocal relationship from BNTX graph: Reciprocal relationship from AUTL graph: Reciprocal relationship from BNTX g…
expenses, including salaries, related benefits, travel and share-based compensation expense for employees engaged in commercial manufacturing functions, external manufacturing costs including outsour…
Reciprocal relationship from LEGN graph: Reciprocal relationship from AUTL graph: Reciprocal relationship from LEGN graph: Reciprocal relationship from AUTL graph: Reciprocal relationship from LEGN g…
Reciprocal relationship from TCRX graph: Reciprocal relationship from AUTL graph: Reciprocal relationship from TCRX graph: Reciprocal relationship from AUTL graph: Reciprocal relationship from TCRX g…
AUTOLUS-LIMITED
AUTOLUS-LIMITED
62%
expenses, including salaries, related benefits, travel and share-based compensation expense for employees engaged in commercial manufacturing functions, external manufacturing costs including outsour…
MILTENYI-BIOTEC-GMBH
MILTENYI-BIOTEC-GMBH
62%
hese contracts, please refer to following notes to the Company’s consolidated financial statements contained in the Company’s Annual Report: • Note 2, “Summary of significant accounting policies” • N…
UCL-BUSINESS-LTD
UCL-BUSINESS-LTD
62%
eporting period beginning after December 15, 2026, and interim reporting periods within annual reporting periods beginning after December 15, 2027. The Company is currently assessing the effect of th…
Autolus Therapeutics plc Debt Obligations
Instrument
Description
Confidence
Evidence
AUTL-DEBT-7986
Warrants outstanding: 7.35
90%
xbrl warrant detail from xbrl 2021-12-31.
Autolus Therapeutics plc Acquisitions
No acquisitions on recordNo completed or pending acquisitions found in our database for Autolus Therapeutics plc.
Autolus Therapeutics plc Ownership
Holder
Name
Confidence
Evidence
AUTL-OWNER-MAK-CAPITAL-ONE-LLC
MAK CAPITAL ONE LLC
90%
13F overlay lists MAK CAPITAL ONE LLC as top holder; 84 tracked holders.
